GLP-1 Receptor Agonist Use and Incidence of Retained Gastric Food on Endoscopy

Medical University of South Carolina260 enrolled

Overview

This study will enroll patients ages 18 and over who are in one of the following groups 1) taking a GLP-1 receptor agonist medication 2) not taking a GLP-1 receptor agonist (control group), are undergoing EGS and have appropriately fasted. Study data will be collected in the form of qualitatively observing whether the stomach is empty as expected, or contains solid or clinically relevant liquid contents.

Study Type

OBSERVATIONAL

Enrollment

260

Conditions

Gastric Content Aspiration

Interventions

EsophagogastroduodenoscopyOTHER

All patients will undergo an esophagogastroduodenoscopy per standard of care, as scheduled.

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria * Adults 18 years of age and older presenting for esophagogastroduodenoscopy (EGD) * One of the following groups: * GLP-1 receptor agonist cohort: active treatment with any GLP-1 receptor agonist therapy within prior 30 days * Control cohort: not taking a GLP-1 receptor agonist medication * Appropriately fasted per ASA Fasting Guidelines Exclusion Criteria * Simultaneous bowel preparation/planned dual endoscopy with colonoscopy * Any pre-planned alteration to standard fasting guidelines (ASA NPO guidelines) * Emergency endoscopic procedure * Concern for active GI bleeding * Food impaction/foreign body as indication for procedure * Gastric outlet obstruction/bowel obstruction * Achalasia * Zenker's diverticulum * History of esophageal or gastric surgery * Active pregnancy * Chronic daily opioid therapy ≥ 15 MMEs per day * Prokinetic agent use (i.e. metoclopramide) * Inability or unwillingness of subject to give informed consent

Locations (1)

Medical University of South Carolina

Charleston, South Carolina, United States

Outcomes

Primary Outcomes

Retained gastric food

Incidence of clinically significant retained gastric food, defined as visible solid/particulate matter, or liquid volume \> 1.5cc/kg

Time frame: From time of enrollment until the end of surgery, assessed up to 4 weeks

Secondary Outcomes

Incidence of pulmonary aspiration event

Time frame: From the time surgery begins until the end of scheduled surgery, assessed up to 24 hours

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.